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lynx1, an Endogenous Toxin-like Modulator
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in the Mammalian CNS
and phospholipases (John et al., 1994), have been identi-
fied as components of snake venom. In some cases,
evidence for a direct evolutionary relationship between
a mammalian gene and a specific toxin gene family has
been obtained. For example, a functional relationship
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One class that lacks functional homologs is the elapidElapid snake venom neurotoxins exert their effects
snake venom neurotoxins that bind to muscle and brainthrough high-affinity interactions with specific neuro-
AChRs. Examples include a-bungarotoxin (aBtx), whichtransmitter receptors. A novel murine gene, lynx1, is
binds to and inhibits nAChRs (Chen and Patrick, 1997),highly expressed in the brain and contains the cyste-
and the muscarinic AChR toxin MT3 (Jolkkonen et al.,ine-rich motif characteristic of this class of neurotox-
1994). An evolutionary relationship has been proposedins. Primary sequence and gene structure analyses
between this class of neurotoxin and the mammalianreveal an evolutionary relationship between lynx1 and
Ly-6 genes based on sequence similarity (Fleming et al.,the Ly-6/neurotoxin gene family. lynx1 is expressed in
1993), conservation of a signature motif, similar tertiarylarge projection neurons in the hippocampus, cortex,
conformation, and common gene structure (Gumley etand cerebellum. In cerebellar neurons, lynx1 protein
al., 1995a). The Ly-6 genes code for cell surface acces-is localized to a specific subdomain including the soma
sory proteins expressed mainly on cells of the immuneand proximal dendrites. lynx1 binding to brain sections
system. They are thought to participate in diverse recog-correlates with the distribution of nAChRs, and appli-
nition and adhesive functions, such as T cell activation,cation of lynx1 to Xenopus oocytes expressing nAChRs
lymphocyte homing, and leukocyte migration (Gumleyresults in an increase in acetylcholine-evoked macro-
et al., 1995a; Hanninen et al., 1997). Despite the evolu-scopic currents. These results identify lynx1 as a novel
tionary and structural similarities, no functional similarityprotein modulator for nAChRs in vitro, which could
between the elapid snake toxins and the Ly-6 genes hashave important implications in the regulation of cholin-
been established (Gumley et al., 1995a), due in part toergic function in vivo.
their disparate sites of action.
In this study, we report the discovery of a novel murine
gene, lynx1, similar to the snake venom neurotoxinsIntroduction
and the Ly-6 antigens of the immune system. A direct
evolutionary relationship between lynx1 and the Ly-6/The correct function of neuronal circuits involves the
neurotoxin superfamily of genes (Chang et al., 1997aprecise regulation of neurotransmitter receptor action.
and 1997b) is supported by primary sequence and geneIn addition to classical studies that have identified a
structure analyses. lynx1 is highly expressed in severalvariety of secreted peptides (Matthes et al., 1998) and
discrete neuronal populations in the brain, and the distri-hormones (Im et al., 1990) that influence receptor activ-
bution of lynx1 binding sites is similar to that of nAChRs.ity, exogenous toxins have been found that bind to and
To test whether lynx1 might be functionally homologousregulate the function of specific neurotransmitter recep-
to the venom toxins, we analyzed its effects on nAChRtors. For example, the snake venom neurotoxins exert
responses in Xenopus oocytes. We report that lynx1their action through high-affinity binding to nicotinic
can act as a novel modulator of nicotinic receptors in(Chen and Patrick, 1997) and muscarinic (Jolkkonen et
vitro, raising the interesting possibility that lynx1 partici-al., 1994) acetylcholine receptors (AChRs). The physio-
pates in a novel mechanism for cholinergic regulationlogical relevance of toxin action rests on the idea that
in vivo.these molecules have evolved from endogenous genes
operating in normal cellular pathways (Ohno et al., 1998).
Functional homologs to important mammalian signaling Results
molecules, including nerve growth factor (NGF) (Inoue
et al., 1991), acetylcholinesterases (Cousin et al., 1998), lynx1 Encodes a Novel Member of the Ly-6/aBtx
Gene Family
In the course of a screen for CNS-specific, developmen-§ To whom correspondence should be addressed (e-mail: heintz@
rockvax.rockefeller.edu). tally regulated cDNAs, we identified a novel cDNA,
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Figure 1. The lynx1 ORF Encodes a GPI-Linked Cell Surface Molecule with Homologies to the Ly-6/aBtx Superfamily
(A) Predicted amino acid sequence of the lynx1 ORF is shown. The boxed N terminus demarcates the putative signal sequence. The C-terminal
transmembrane domain that is cleaved during the processing of the GPI anchor is boxed. The consensus recognition sequence for the
attachment of the GPI moiety is indicated in brackets (Udenfriend and Kodukula, 1995). Nonpolar residues are shaded. Arrowheads designate
the position of the intron breaks in the lynx gene.
(B) Amino acid sequence homology between lynx1 and members of the Ly-6/aBtx gene superfamily. Family members comprise two groups:
the lymphocyte cell surface antigens E48, Ly-6 A/E, and CD59, and the elapid snake venom toxin peptides a-cobratoxin (aCtx), aBtx, and
m3 toxin (M3tx). The putative mature amino acid sequence only was used for these alignments. The Ly-6 consensus motif is shown above.
Residues corresponding to this consensus are shaded in black. Residues matching the lynx1 polypeptide are shaded in gray. Numbers at
the right indicate the percentage similarity and identity, respectively, to the lynx1 mature polypeptide.
GC26, expressed in the mouse cerebellum (Kuhar et al., Database searches of the GC26 amino acid sequence
(Altschul et al., 1990) demonstrated similarity (18%±1993). To further pursue the characterization of GC26,
we undertook the isolation of a full-length GC26 cDNA 50%) to a family of small cysteine-rich proteins compris-
ing the secreted elapid snake venom neurotoxins (Hungclone (4.1 kb) through several rounds of cerebellar cDNA
library screening. Sequence analysis of this cDNA re- et al., 1998) and the Ly-6 GPI-linked cell surface acces-
sory molecules of the immune system (Figure 2B; Flem-vealed a short (351 bp) open reading frame (ORF) encod-
ing a protein of a predicted size of 11 kDa (Figure 1). ing et al., 1993; Brakenhoff et al., 1995; Gumley et al.,
1995a, 1995b). A characteristic feature of the Ly-6 andThis ORF was verified by in vitro translation of the mRNA
encoded by GC26 and electrophoretic analysis of the the a-neurotoxin proteins is the presence of a cysteine-
rich consensus motif consisting of an N-terminal leu-resulting protein product (data not shown). Analysis of
the predicted polypeptide sequence demonstrated that cine/isoleucine, eight cysteines, and a C-terminal aspar-
agine. Alignment of GC26 with the Ly-6 proteins and theGC26 codes for a protein containing an N-terminal signal
sequence and a hydrophobic C-terminal domain match- snake neurotoxins demonstrated that GC26 contains
this signature motif (Figure 2B). The overall sequenceing the consensus for addition of a GPI anchor (Uden-
friend and Kodukula, 1995; Figure 2A). The N terminus similarity between lynx1 and the Ly-6/neurotoxin gene
family, and the conservation of this signature cysteine-encoded a consensus signal sequence that was later
demonstrated to be functional by transfection of a fusion rich motif, prompted us to name the GC26 polypeptide
lynx1 (Ly-6/neurotoxin).construct containing the signal sequence and the ma-
ture polypeptide in frame with the hemagglutinin epitope Structural data for members of this superfamily, such
as CD59, aBtx, and cobratoxin, demonstrate a strikingly(HA). In these cells, mature HA-tagged product was se-
creted into the culture supernatant (data not shown). similar tertiary structure (Le Goas et al., 1992; Basus et
Figure 2. Comparison of the lynx1 Model and
the aBtx Experimental Structure
(A) Three-dimensional model of lynx1. Strands
are shown as green arrows and disulfide
bridges are colored yellow.
(B) Experimental NMR structure of aBtx (PDB
code 1abt). The orientation and coloring is
the same as for lynx1. N- and C-terminal ends
of the molecules are labeled.
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al., 1993; Fletcher et al., 1994), despite their low overall
sequence similarity. This is due to the fact that the con-
served cysteine residues that constitute the Ly-6/neuro-
toxin motif are critical determinants in the overall topol-
ogy of these molecules. The disulfide bonds created by
these conserved cysteines create a rigid b sheet core,
out of which three variable loops emerge. Conservation
within lynx1 of these critical residues suggest that lynx1
is structurally related to the snake toxins and can adopt
its receptor binding fold. To test whether or not lynx1
adopts the snake toxin fold, comparative models of
lynx1 were built using three different template structures
with the snake toxin fold (Figure 2). Experimental struc-
tures of CD59, aBtx, and cardiotoxin were used indepen-
dently and in combination with each other to produce
four different models. The evaluation of the models indi-
cated that all four of them are reliable with a probability
of having the correct fold of 0.84, 0.91, 0.93, and 0.94
for the best models based on CD59, cardiotoxin, aBtx,
and all three templates, respectively. This indicates that
the best individual template structure for lynx1 is aBtx,
Figure 3. The lynx1 Gene Shows Similar Gene Organization with the
although the model based on all three templates is the Ly-6/Neurotoxin Gene Superfamily
best model produced. This is not surprising, since the (A) Representation of the coding exons of the lynx1 gene as com-
use of more than one related template usually improves pared to members of the Ly-6 superfamily, mThB (Gumley et al.,
the quality of the resulting comparative model (SaÂ nchez 1995b), Ly-6C (Fleming et al., 1993), and cobratoxin (Chang et al.,
1997b). These intron breaks occur in similar positions as those ofand SÆ ali, 1997). The false-positive rate of the evaluation
the Ly-6 genes mThB (Gumley et al., 1995b), E48 (Brakenhoff etprocedure for models of this size (70 residues) is only
al., 1997), and erabutoxin (Fuse et al., 1990). In (A), the exons are7% (SaÂ nchez and SÆ ali, 1998). As a negative control, a
represented as boxes and are not to scale. The red shading within
model for lynx1 was built based on bovine pancreatic the boxes represents the 59 UTR, the orange shading represents
trypsin inhibitor (BPTI), a small disulfide-rich protein that the signal sequence (Sig Seq), the yellow shading represent the
does not adopt the snake toxin fold. The probability of mature protein, the green shading represents the hydrophobic GPI
consensus sequence, and the blue shading represents the 39 UTR.having the correct fold for this model was ,0.5 (i.e.,
The conserved residues that make up the consensus motif are des-0.28), supporting the prediction that lynx1 can in fact
ignated within the yellow portion of the second and third exons.adopt the snake toxin fold.
(B) One highly conserved intron break occurs within the signal se-
An evolutionary relationship between the Ly-6 genes quence, three residues prior to the first leucine of the mature poly-
and the snake venom toxins has been proposed based peptide. The signal sequence is underlined, and the sequence corre-
on conservation of intron±exon boundaries in the coding sponding to the mature protein is designated in bold. The residues
of the consensus are boxed, and the starting residue of the matureportions of these genes (Fuse et al., 1990; Chang et al.,
protein, leucine, is designated with a hatch. The arrow indicates the1997a and 1997b). The Ly-6 and a-neurotoxin genes
position of the intron break in the genomic sequence.have a conserved intron dividing the signal sequence
into two exons, and another intron interrupting the ma-
ture polypeptide between the third and fourth conserved
snake neurotoxin gene and that it is a novel member ofcysteine residues. To assess whether lynx1 belongs to
this superfamily.the Ly-6/neurotoxin superfamily, we determined the
lynx1 gene structure. lynx1 genomic clones were ob-
tained through screening a bacterial artificial chromo-
lynx1 Is Highly Expressed in the Mammalian CNSsome library (BAC) of mouse genomic DNA. A lynx1-
To gain insight into the potential role of lynx1 in vivo,containing BAC was verified by Southern analysis,
we first determined its pattern of expression. Northernsubcloned and sequenced, and compared against the
blot analyses demonstrated that lynx1 mRNA is highlylynx1 cDNA sequence. As shown, the intron±exon
enriched in the brain, although low levels can be de-boundaries in the lynx1 gene are located within the puta-
tected in other tissues such as kidney (Figure 4A), heart,tive signal sequence and in the region corresponding
and thymus (data not shown). Northern blot analyses atto the second loop in lynx1, as previously documented
various stages of cerebellar development demonstratefor Ly-6 and cobratoxin genes (Figures 3A and 3B). In
that lynx1 is expressed at very low levels at birth andaddition, several of the mammalian Ly-6 genes have
undergoes a marked upregulation between postnatalbeen independently cloned, and genetic mapping ex-
days 10 and 20 (Kuhar et al., 1993). In situ hybridizationperiments show that many of these family members map
to adult brain sections revealed that lynx1 is highly ex-to the same chromosomal position in the mouse genome
pressed in subsets of neurons in multiple brain struc-(Gumley et al., 1995a). Genetic mapping of lynx1 in mice
tures (Figure 4B), including Purkinje cells and deep nu-determined that it maps to the Ly-6 gene cluster
clear neurons of the cerebellum (Figures 4Ba and 4Bb),(J. M. M., C. F. Fletcher, N. A. Jenkins, N. G. Copeland,
deep layer pyramidal neurons in the cerebral cortex (Fig-and N. H., submitted). We conclude that lynx1 is evolu-
tionarily related to both the Ly-6 gene and the elapid ure 4Bd), CA3 pyramidal cells and hilar neurons of the
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Figure 4. Expression of the lynx1 Gene Is Highly Enriched in Specific Regions
To test the expression pattern of the lynx1 message, multiple tissues were tested by Northern analysis, and in situ hybridization was carried
out on mouse brain sections.
(A) Northern blot analysis of lynx1 gene expression. Poly(A)1 RNA from adult murine tissues (as indicated) was probed with the lynx1 cDNA
(upper panel) and with a GAPDH loading control (lower panel). lynx1 is highly expressed in the brain, with lower levels of expression in the
kidney. The lynx1 cDNA hybridizes to a band of z4.0 kb.
(B) In situ hybridization analysis demonstrates lynx1 expression in subsets of neurons across multiple circuits in the brain.
(a±b) Bright- and dark-field photomicrographs, respectively, of the same field of the mouse cerebellum reacted with the lynx1 antisense
35S-labeled riboprobe.
(b) lynx1 is detected in the Purkinje cell body layer (PC) and the deep cerebellar nuclei (DCN).
(c) No signal is observed with the sense control probe.
(d±f) lynx1 expression is high in the deep layers of the cerebral cortex (V/VI) (d), CA3 pyramidal neurons of the hippocampal formation (e),
and mitral cells of the olfactory bulb (MC) (f).
hippocampus (Figure 4Be), and mitral cells of the olfac- specific subdomain within individual neurons. Cerebel-
lar Purkinje cells are a useful model system for thistory bulb (Figure 4Bf). No detectable signal was ob-
analysis, as they are highly polarized neurons with anserved with the sense control probe (Figure 4Bc). High-
elaborate dendritic tree that is compartmentalized intoresolution colorimetric in situ hybridization analysis
discrete subdomains defined by segregated afferentdemonstrated expression within individual neurons (Fig-
types. These subdomains include proximal dendritesures 5A±5D) in these structures and revealed dramatic
receiving inputs from climbing fibers, diffuse cholinergicdifferences in the levels of expression of lynx1 between
terminals, and inhibitory stellate and basket neurons inspecific neuronal populations.
addition to the distal dendritic compartment, innervated
by parallel fibers onto dendritic spines (Larramendi and
lynx1 Is Expressed in a Neuronal Subdomain Viktor, 1967). Immunostaining with the lynx1 antiserum
We next examined lynx1 protein distribution by immuno- revealed that lynx1 is present on Purkinje cell soma and
proximal dendrites (Figures 6A and 6C), in contrast to thecytochemistry to determine if lynx1 is localized to a
Figure 5. High Levels of Expression of lynx1
in Discrete Neuronal Subpopulations; Colori-
metric In Situ Hybridization Detects lynx1
mRNA in Individual Neurons
(A±B) Message levels in the hippocampal for-
mation are very high in neurons of the CA2/
CA3 region of the hippocampus, at medium
and high power, respectively. High levels of
message are found within individual neurons
of the hilar region (HR).
(C) Message levels show laminar differences
in the cerebral cortex, with highest levels of
expression found in the lower layers (V/VI),
no detectable message in layer IV, and little
to no detectable message in the upper layers
(I/II/III).
(D) High levels of message are detected in
individual neurons of the cortex. Substrate
deposition in the cytoplasm reveals pyrami-
dal neurons that are highly positive for lynx1
message (arrows).
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Figure 6. The lynx1 Protein Is Localized to
a Subdomain within the Dendritic Arbor of
Purkinje Cells of the Cerebellar Cortex
(A±D) Immunocytochemistry on mouse cere-
bellar sections shows specific localization of
the lynx1 protein.
(A and C) Low- and higher-power photomi-
crographs of mouse cerebellum immuno-
stained with lynx1 peptide antiserum. lynx1
expression is confined to proximal dendrites
and soma of Purkinje cells in the cerebellar
cortex.
(B) No staining is observed with preimmune
control serum.
(C and D) Adjacent serial sections reacted
with anti-lynx1 and anti-calbindin antisera,
respectively, showing the limited distribution
of lynx1 as compared to calbindin.
(E and F) Immunofluorescence analysis of
lynx1 protein localization.
(E) Calbindin antiserum (green) labels the
complete dendritic arbor of Purkinje cells, in-
cluding the finely articulated spiny branch-
lets, whereas lynx1 antiserum (red) labels only
the proximal dendritic branches of these
neurons.
(F) The profile of inhibitory synapses onto
Purkinje cells, as revealed by anti-GAD immu-
noreactivity (green), shows inhibitory synap-
tic termini closely apposed to lynx1-positive
postsynaptic domains (red). This is in con-
trast to the profile of all synapses, which is
densely packed and evenly distributed across
the molecular layer of the cerebellum and not
confined to a dendritic subfield (data not
shown).
staining observed with antiserum against the calcium lynx1 Binds to Specific CNS Neurons
To assess whether lynx1 functions through interactionsbinding protein calbindin, which labels the entire Pur-
kinje cell dendritic arbor (Figure 6D), and with preim- with a specific binding partner, a receptor affinity probe
was generated by cloning lynx1 in frame with the Fcmune controls, which show no signal (Figure 6B). This
distribution is also observed by double immunofluores- portion of human immunoglobulin (lynx1/Fc). The lynx1/
Fc fusion protein was used to perform binding assayscence staining and visualization with the confocal micro-
scope comparing the distribution of lynx1 and calbindin on sections of adult cerebellar tissue. Binding of lynx1
was detected on the Purkinje cell soma and proximalin single Purkinje cells (Figure 6E). These data indicate
that lynx1 is localized to the proximal somatodendritic dendrites, as well as on basket and stellate neurons
resident in the molecular layer of the cerebellar cortexcompartment, which receives most of the inhibitory in-
puts onto Purkinje cells. (Figures 7A and 7B). This binding was specific, since
purified lynx1 competed the binding of the lynx1/Fc fu-We also compared the distribution of lynx1 protein
within this domain to glutamic acid decarboxylase (GAD), sion, and no binding was observed using the Fc frag-
ment alone (Figures 7C and 7D). The pattern of lynx1which is highly expressed in presynaptic terminals of
inhibitory interneurons. Comparison of GAD distribution binding includes the lynx1-positive subdomain of cere-
bellar Purkinje cells, as well as interneuron cell bodieswith the localization of lynx1 demonstrates lynx1-posi-
tive sites in apposition to inhibitory presynaptic termi- that do not express significant levels of lynx1. Interest-
ingly, this pattern of binding is similar to the distributionnals, confirming that lynx1 is present in the proximal
postsynaptic compartment (Figure 6F). lynx1, however, of nAChRs reported in the literature and as assayed by
a7 nAChR immunoreactivity (data not shown; Domin-displays a much broader distribution than the synaptic
regions revealed by GAD staining. Thus, lynx1 protein guez Del Toro et al., 1994). These results strongly sug-
gest that lynx1 can form heterotypic interactions withis maximally expressed in a neuronal subdomain that
correlates with the distribution of a defined subset of a CNS receptor, but they do not rule out homotypic
interactions between lynx1 molecules on the surface ofafferent inputs, but it is not restricted to discrete post-
synaptic sites within this subdomain. lynx1-expressing cells.
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Figure 7. Localization of lynx1 Binding Sites
in the Cerebellar Cortex
(A and B) Binding of lynx1/Fc fusion protein
to sections of the cerebellar cortex detected
either by indirect immunofluorescence (A) or
immunocytochemistry (B). In both cases, Pur-
kinje cell somata and proximal dendrites, as
well as basket and stellate cell bodies
(arrows), are detected.
(C) Binding of the Fc fragment to cerebellar
slices reveals no specific labeling.
(D) Preincubation of sections with recombi-
nant lynx1 specifically inhibits the binding of
the lynx1/Fc fusion protein.
lynx1 Can Modulate Nicotinic Acetylcholine tion of lynx1 enhanced the amplitude of the ACh-evoked
macroscopic currents by 30%±40% compared with non-Receptor Function In Vitro
To test whether lynx1 functions through AChRs, we ex- treatment or column-passed PBS controls (n 5 8 oo-
cytes, mean increase z35%, p 5 0.001). lynx1 applica-amined ACh-elicited macroscopic current responses in
control and lynx1-treated Xenopus oocytes expressing tion augmented ACh-evoked currents within the first or
second posttreatment trials and exhibited similar activ-recombinant a4b2 nAChR subunit cRNAs (Figure 8). In-
jected oocytes were assayed in voltage clamp, and in- ity with all ACh concentrations tested (10 mM to 1 mM).
Similar results were obtained on a7 homomers, and withward current responses to ACh were measured for z30
min before and after treatment with purified lynx1. Se- multiple lynx1 preparations obtained from different het-
erologous expression systems, including conditionedquential preapplication responses to ACh (1 mM, 20 s)
differed by less than 2%±3% when trials were separated media from mammalian cells transfected with lynx1±HA
or lynx1±alkaline phosphatase (AP) fusion constructs,by 5 min intervals. After a stable baseline was estab-
lished, a 20 s pulse of lynx1 solution was applied, after and bacterially expressed lynx1 (data not shown). During
the 20 s preapplication of lynx1, in the absence of ACh,which the first test pulse of ACh was delivered. Applica-
Figure 8. lynx1 Increases ACh-Gated Macro-
scopic Current Responses
ACh-elicited macroscopic current responses
in voltage-clamped Xenopus oocytes ex-
pressing a4b2 nAChRs.
(A) Representative macroscopic current re-
sponses to 1 mM ACh under control condi-
tions (above) and in the second ACh trial, fol-
lowing lynx1 treatment.
(B) Plot of cumulative results from eight
experiments. Column-purified lynx1 (1%, in
oocyte recording media; see Experimental
Procedures) significantly increases the am-
plitude of macroscopic current responses to
ACh (1 mM, 20 s application, 5 min intertrial
interval). Each experiment represents 20±60
ACh-evoked responses per condition includ-
ing the pretreatment controls (set to 100%)
column-purified lynx1 and a PBS control
(cPBS). The latter control solution is the run-
ning buffer for the lynx1 purification column,
collected following isolation of the active
lynx1 fractions.
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no lynx1-evoked currents were detected in five of the nervous system. The mode of action of ACh in the CNS is
unusual in that the majority of both cholinergic terminalssix lynx1 preparations tested. As lynx1 does not repro-
ducibly elicit currents when applied alone, we conclude from central projections and AChRs on target cells are
diffusely distributed and extrasynaptic (Contant et al.,that lynx1 is not a ligand or neurotransmitter but that it
has the capacity to modulate receptor function in the 1996), although direct action of ACh at central synapses
has been demonstrated (McGehee et al., 1995; Gray etpresence of its natural ligand, ACh. Taken together,
these data demonstrate that lynx1 can act as a modula- al., 1996). This has led to the hypothesis that cholinergic
terminals modulate cell excitability through release oftor of AChR function in vitro. Furthermore, the action of
lynx1 on these receptors is distinct from that of the ambient levels of ACh (Descarries et al., 1997). One
intriguing possibility is that lynx1 is important for regulat-neurotoxins, since in the presence of lynx1 we observe
an increase rather than a decrease in ACh-evoked mac- ing the response of extrasynaptic receptors to these
ambient levels of ACh in selected populations of neu-roscopic currents through these receptors.
rons. Since cholinergic inputs have been implicated in
many important functions, including learning and mem-Discussion
ory, attention, and sleep±wake cycles (Picciotto et al.,
1995; Everitt and Robbins, 1997; Robbins, 1997; ChangeuxThe data we have presented in this study identify lynx1
et al., 1998; Coull, 1998), and since the loss of centralas a novel member of the Ly-6/neurotoxin gene super-
cholinergic function may be an important factor in thefamily, highly expressed in discrete neurons of the CNS.
decline of cognitive function with age (Gallagher andIn vitro tests reveal that application of lynx1 to nAChRs
Rapp, 1997) and in Alzheimer's disease (Robbins et al.,results in an increase in ACh-evoked currents through
1997; Geula, 1998), an involvement of lynx1 in modula-these receptors. These results demonstrate that lynx1
tion of cholinergic function in vivo would be very im-can act as a novel modulator of AChR function, which
portant.could have important implications for cholinergic func-
Further investigations will be required to understandtion in vivo.
the mechanism of action of lynx1 on AChRs in vitro,The assignment of lynx1 to the Ly-6/neurotoxin gene
including its possible direct binding to AChR subunits,superfamily is based on overall sequence similarity, con-
its specificity for AChR subtypes, and the detailed mech-servation of the cysteine-rich consensus motif, and
anism whereby it modulates AChR function. Moreover,common gene structure with members of this superfam-
while our data point to AChR as a likely target for lynx1ily. Given the importance of the conserved cysteines as
actions, we cannot rule out the possibility that othercritical determinants of topology, their presence in lynx1
receptors or binding proteins could be the physiologicalsuggested it might adopt a similar three-looped ªtoxin
targets for lynx1. Genetic manipulations and behavioralfold.º This led us to explore the possibility that lynx1
tests will ultimately be required to elucidate the precisemay bind to specific receptors in the CNS. Interestingly,
function of lynx1 in vivo. Finally, the discovery of lynx1binding of lynx1 to brain sections revealed a pattern
as a novel toxin-like CNS protein and the demonstrationsimilar to that of the nAChRs. For example, in the cere-
of its impact on nicotinic AChR function raise the issuebellum, lynx1 binds to Purkinje cell proximal compart-
of the existence of other ªprototoxinº genes and theirments and to interneurons presynaptic to Purkinje cells,
possible roles in CNS function. Given the large numbermatching the localization of a7 AChRs (Dominguez Del
of protein toxins identified in snakes and invertebratesToro et al., 1994). As lynx1 is detected in Purkinje cells
and their wide-ranging specificity for different receptors,alone, these data demonstrate that lynx1 can interact
channels, and proteins (Dufton and Harvey, 1989; Ademwith a binding protein present in cell types that do not
and Karlsson, 1997; Harvey, 1997; Kumar et al., 1997),express significant levels of lynx1. Thus, this establishes
it seems probable that other genes of this type may bethat lynx1 can form heterotypic interactions and that
present in mammals. Studies of these putative proto-nAChRs are a probable candidate for this interaction.
toxin genes may reveal new molecular mechanisms thatThis, taken together with our supposition that lynx1 was
have a critical impact upon vertebrate brain function.the functional homolog to snake toxins, prompted us to
test the effect of lynx1 on nAChRs in vitro. This assay
reveals that lynx1 can enhance the function of these Experimental Procedures
receptors in the presence of its natural ligand, identifying
cDNA Library Screeninglynx1 as a novel modulator of nAChRs in vitro. Neuro-
Library screening was conducted on an oligo-dT primed l zap cDNApeptide modulators of receptor function, such as so-
library synthesized from adult murine cerebellar RNA, using a 1.5
matostatin and opioids, are released from the presynap- kb Sfi1-Not1 fragment from the GC26 cDNA (GC26-1). The predicted
tic terminals into the synaptic cleft (Maley et al., 1987; amino acid sequence from the ORF of the full-length cDNA (lynx1-3)
Garside and Mazurek, 1997), whereas lynx1 is normally was used to search GenBank with tblastn and blastp search algo-
rithms, using PAM250 and default parameters. Amino acid sequencepresent at the cell surface as a GPI-anchored protein.
alignments were performed using the ClustalW algorithm (MacVec-This raises the possibility, therefore, that lynx1 is op-
tor, DNAstar).erating on nAChRs via a novel mechanism.
The observation that both nAChRs and lynx1 are ex-
Structural Modelingpressed at extrasynaptic sites on the soma and proximal
Three-dimensional models of lynx1 were built automatically by thedendrites of Purkinje cells may be an important clue to
computer program MODELLER-5 (SÆ ali and Blundell, 1993). MOD-
the in vivo function of lynx1. One of the main characteris- ELLER-5 implements comparative modeling by satisfaction of spa-
tics of the cholinergic projections from the brainstem tial restraints (SÆ ali and Blundell, 1993). The input to MODELLER-5
was a multiple alignment of lynx1 with members of the snake toxinare their wide and diffuse distribution throughout the
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fold family of known three-dimensional structure. The alignment on a freezing microtome. The sections were blocked with 10% NGS,
0.05% Triton X-100 in PBS and incubated in anti-lynx1 antiserumwas prepared by hand following the pattern of conserved cysteine
residues. First, MODELLER-5 derived many distance and dihedral for 1 hr at room temperature at a dilution of 1:8,000 or anti-calbindin
antibodies (SWant) at 1:10,000. Antibody binding was visualizedangle restraints on the lynx1 sequence from the alignment with the
template proteins. One additional restraint was added manually to using the ABC Elite kit (Vector) according to the manufacturer's
instructions and reacted with H2O2/DAB substrate.force a disulfide bridge between cysteine 6 and cysteine 11 in lynx1.
Next, these homology-derived spatial restraints and CHARMM-22
energy terms (Brooks et al., 1983) enforcing proper stereochemistry Immunofluorescence
were combined into an objective function. Finally, the variable target Sections were prepared as above. The lynx1 antiserum was used
function procedure, which employs methods of conjugate gradients at 1:2,000 and detected with goat anti-rabbit secondary antibody
and molecular dynamics with simulated annealing, was used to conjugated to Cy3 (Jackson Immunochemicals). Double labeling
obtain the three-dimensional models by optimizing the objective with anti-GAD was performed at 1:1,000 (Boerhinger Mannheim) and
function. In each case, ten slightly different three-dimensional mod- detected with goat anti-mouse Cy5 at 1:800 (Jackson Immunochem-
els were calculated by varying the initial structure. icals). Labeling was imaged on a scanning laser confocal micro-
Since the sequence similarity between lynx1 and the members of scope (Zeiss).
the snake toxin fold family is not striking, different members of that
family were used as templates. Specifically, CD59 (PDB code 1erg), Affinity Binding Assay
aBtx (1abt), and cardiotoxin (1tgx) were used individually and in The lynx1 cDNA corresponding to the mature lynx1 protein with its
combination with each other as structural templates. BPTI (6pti), native signal sequence was cloned in frame 59 to the Fc portion of
another small disulfide-rich protein that does not adopt the snake human IgG (lynx1/Fc). The control used was a secreted, unfused
toxin fold, was used as a template to test the ability of the evaluation Fc construct. Constructs were transfected and treated as above,
procedure to detect incorrect folds. The reliability of the resulting then concentrated 1:20 in an Ultrafree-Biomax spin column (Milli-
models was predicted by a procedure based on statistical potentials pore). The lynx1 fusion protein was normalized against the control
of mean force (Sippl, 1993) and using the resulting scores to predict by Western analysis. Binding experiments were performed on 50
the probability that the models have the correct fold by a procedure mm vibratome sections of perfused mouse brains (as above). The
described by SaÂ nchez and SÆ ali (1998). sections were blocked in 10% NGS in PBS, reacted with lynx1/Fc
for 1 hr, and washed. lynx1/Fc binding was detected with goat
Genomic Analysis anti-human IgG Cy3 at 1:1,000 (Jackson Immunochemicals) and
A 1.5 kb fragment of the 39 UTR region (GC26-1) was used as a detected by epifluorescence microscopy using a rhodamine filter.
probe to screen a BAC library of mouse genomic DNA (Research Pet264 bacterial fusion protein was used for the competition experi-
Genetics) under stringent conditions (658C, 0.23 SSC, 0.1% SDS). ments (see above).
A lynx1 gene±containing BAC clone (BAClynx1-9) was verified by
Southern analysis using the GC26-1 and the ORF of lynx1-3 as lynx1 Preparation for Oocyte Recording
probes. The BAC was PCR amplified using cDNA-specific primers, The lynx1 cDNA corresponding to the lynx1 mature protein with its
subcloned, and sequenced. Genomic sequence was compared native signal sequence and without the GPI consensus sequence
against cDNA sequence to verify intron±exon boundaries. was cloned in frame with the HA epitope, downstream of the CMV
promoter (referred to as CMV2611). CMV2611 constructs were
Northern Blot transfected into 293T cells, which were cultured for 3 days before
Tissue was dissected and frozen in liquid nitrogen; RNA was ex- supernatants were harvested. HEPES (5 nM [pH 7.2]) was added to
tracted in guanidinium±thiocyanate according to standard methods. the cultured supernatants, which were then precipitated with 50%
Poly(A)1 RNA was purified using oligo-dT chromatography. RNA ammonium sulfate. The pellet was resuspended in PBS and fraction-
(5 mg) was electrophoretically separated, blotted onto Genescreen ated on a Pharmacia Hiload Superdex 16/60 gel filtration column.
nylon membrane, probed overnight at 428C, and washed at a strin- lynx1-containing fractions were detected by Western blotting or dot
gency of 0.53 SSC, 0.1% SDS at 658C. The probe was made by blotting assays using anti-HA antibody (Boehringer-Mannheim).
random primed labeling of the lynx1-3 ORF.
Xenopus Oocytes and cRNA Preparation and Injection
In Situ Hybridization Xenopus oocytes were collected and incubated in 2 mg/ml collagen-
In situ hybridization analyses were conducted on 10 mm fresh frozen ase (Type I, Sigma) in ND96 (Specialty Media) for 3±4 hr at room
sections of adult mouse brain. GC26-1, the lynx1 39 UTR, was used temperature. Oocytes were then washed four times with Barth's
for these experiments. In the radioactive method, one million counts medium, transferred to L-15 medium, and allowed to recover at
of 35S-labeled riboprobe were applied to each section and washed 188C overnight before cRNA injection. Oocytes were maintained in
to a stringency of 0.13 SSPE at 658C. The slides were exposed L-15 at 188C after cRNA injection, and experiments were performed
and developed under standard conditions and counterstained with between 1 and 7 days after injection. cDNAs encoding chicken
cresyl violet. In the colorimetric method, digoxigenin- (Dig-) labeled nAChR subunits a4 and b2 in the PGH19 oocyte expression vector
riboprobe was transcribed using 0.5 mm Dig±UTP (Boehringer- were linearized and used as templates for run-off transcription using
Mannheim) in the transcription reaction. Sections were incubated the T7 promoter. Oocytes were injected with 20 nl of cRNA at a final
at 658C overnight in hybridization buffer (50% formamide, 300 mM concentration of z0.05 ng/ml. a4 and b2 cRNAs were injected at a
NaCl, 50 mM Tris, 1 mM EDTA, 1% Denhardt's reagent, 10% dextran ratio of 1:1.
sulfate, and 0.1 mg/ml yeast tRNA [pH 8.0]) and washed to a final
stringency of 0.23 SSC at 658C. Riboprobe was detected with anti- Electrophysiological Recording, Data Acquisition, and Analysis
Dig Fab fragments conjugated to AP and NBT/BCIP/levamisole sub- Macroscopic currents were recorded with a GeneClamp 500 ampli-
strate mixture. fier (Axon Instruments) using a two-electrode voltage clamp with
active ground configuration. Electrode resistances ranged between
0.5 and 5 MV and were filled with 3 M KCl. Membrane potentialImmunocytochemistry
Peptide antibodies were generated from the peptide sequence was clamped to 270 mV; only oocytes with leak currents of ,100
nA were used. The extracellular recording solution included (in mM):TTRTYFTPYRMKVRKS. Antisera were screened by Western blots of
bacterially expressed lynx1 fusion protein and on mouse cerebellar 82.5 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES (pH 7.5) (all
reagents from Sigma). Uninjected and mock-injected oocytes didextracts. Briefly, a portion of the lynx1 cDNA, corresponding only
to the mature polypeptide, was cloned in frame to six histidines not respond to ACh, rendering the inclusion of atropine in the extra-
cellular perfusion solution unnecessary. ACh (RBI) was prepared inusing the pet14b bacterial expression vector (Pet264). Transformed
cells were induced, and protein was purified using Ni resin (Qiagen) extracellular solution at concentrations of 10 mM to 1 mM. Oocytes
were perfused at z5 ml/min and were exposed to sequential, 20 sand eluted. Adult mouse brains were perfused with 4% paraformal-
dehyde/PBS, sunk in 30% sucrose/PBS, and sectioned at 20 mm applications of agonist with 5 min intertrial intervals. Stable baseline
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responses to ACh (i.e., an intertrial variance of ,2.5%) are typically from electrophysiology, functional neuroimaging and psychophar-
macology. Prog. Neurobiol. 55, 343±361.achieved within two to three trials under these recording conditions.
Following an initial assessment of four sequential pretreatment re- Cousin, X., Bon, S., Massoulie, J., and Bon, C. (1998). Identification
sponses to ACh, solutions containing either 1% column-passed of a novel type of alternatively spliced exon from the acetylcholines-
PBS or column-purified lynx1 in PBS were applied to oocytes for terase gene of Bungarus fasciatus. Molecular forms of acetylcholin-
20 s. ACh-evoked macroscopic currents were recorded again, im- esterase in the snake liver and muscle. J. Biol. Chem. 273, 9812±
mediately after exposure to the test solution (t 5 0) and at 5 min 9830.
intervals thereafter (t 5 1±5). Oocytes were perfused in control me- Davidson, F.F, and Dennis, E.A. (1990). Evolutionary relationships
dium for 30 min before the next test solution was applied. Macro- and implication for the regulation of phospholipase A2 from snake
scopic currents were recorded and the rise times, amplitude, and venom to human secreted forms. J. Mol. Evol. 31, 228±238.
time course of the elicited currents were analyzed using Pclamp6
Descarries, L., Gisiger, V., and Steriade, M. (1997). Diffuse transmis-(Axon Instruments). Graphical and statistical analyses utilized Origin
sion by acetylcholine in the CNS. Prog. Neurobiol. 53, 603±725.5.1 (Microcal Software).
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